KLK3 and prostate carcinoma: An established parameter for early diagnosis of prostate carcinoma (PCa) is the prostate-specific antigen (PSA), which exhibits a high diagnostic sensitivity of 91%, but a low specificity of only 14% (2.5 ng/mL as cutoff) [1].